Influence of the Basal Ganglia on Cerebellar Action
Project Number5R01NS044592-04
Contact PI/Project LeaderGIBSON, ALAN R
Awardee OrganizationST. JOSEPH'S HOSPITAL AND MEDICAL CENTER
Description
Abstract Text
DESCRIPTION (provided by applicant): Diseases affecting the basal ganglia produce a variety of movement deficits, and these deficits are often totally disabling. Parkinson's disease, which affects about 1.5 million Americans, is a basal gangliar disease that leads to tremor, decreased spontaneous movement and slowness of voluntary movement. Drug treatment of Parkinson's disease with L-DOPA is only partially effective in relieving the motor symptoms of the disease, and prolonged drug treatment leads to severe side effects such as uncontrollable involuntary movements. Deep brain stimulation at specific sites in the basal ganglia can provide effective relief of Parkinson symptoms. Neither drug treatment nor deep brain stimulation restores damaged neural circuitry in the basal ganglia. Therefore, it is likely that these therapies prevent abnormal basal gangliar output from disrupting processing in other structures related to movement control. One major neural structure related to movement control is the cerebellum, but there are no direct connections between the cerebellum and the basal ganglia. We have discovered that disrupting activity in the cat red nucleus, which connects cerebellar output to the spinal cord, can produce motor symptoms that are strikingly similar to those of Parkinson's disease. The general hypothesis underlying this proposal is that motor deficits produced by basal gangliar disease are mediated by pathways that allow basal gangliar output to disturb processing in structures related to the cerebellum. Specifically, we hypothesize that basal gangliar output from the cat entopeduncular nucleus affects activity of cells in zona incerta, which affects activity of cells in the red nucleus. Our experiments will: 1. Identify regions in the related nuclei that contain cells related to forelimb movement. 2. Determine how these forelimb regions affect movement with activation and inactivation by injection of receptor antagonists. 3. Develop an acute and chronic cat model of basal gangliar disease to test critical aspects of the hypothesis. 4. Identify additional brainstem pathways that allow basal gangliar output to influence cerebellar circuits. The results will provide a deeper understanding of how the basal ganglia and cerebellum interact to control limb movements and will lead to new approaches for the treatment of movement disorders.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
131606022
UEI
SKX6AXF9ZTM3
Project Start Date
01-January-2004
Project End Date
31-December-2009
Budget Start Date
01-January-2007
Budget End Date
31-December-2009
Project Funding Information for 2007
Total Funding
$385,843
Direct Costs
$219,267
Indirect Costs
$166,576
Year
Funding IC
FY Total Cost by IC
2007
National Institute of Neurological Disorders and Stroke
$385,843
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS044592-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS044592-04
Patents
No Patents information available for 5R01NS044592-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS044592-04
Clinical Studies
No Clinical Studies information available for 5R01NS044592-04
News and More
Related News Releases
No news release information available for 5R01NS044592-04
History
No Historical information available for 5R01NS044592-04
Similar Projects
No Similar Projects information available for 5R01NS044592-04